{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:43:29Z","timestamp":1786167809510,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-026-02044-9","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:04:44Z","timestamp":1782799484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Radiological Variability in Episodic Ataxia Type 2: A Case Report and Review of the Literature"],"prefix":"10.1007","volume":"25","author":[{"given":"Juan Fernando","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auki Guaillas","family":"Japon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila D.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Lannen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"2044_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jns.2016.10.029","volume":"371","author":"L Pradotto","year":"2016","unstructured":"Pradotto L, Mencarelli M, Bigoni M, Milesi A, Di Blasio A, Mauro A. Episodic ataxia and SCA6 within the same family due to the D302N CACNA1A gene mutation. J Neurol Sci. 2016;371:81\u20134. https:\/\/doi.org\/10.1016\/j.jns.2016.10.029 . PubMed PMID: 27871455.","journal-title":"J Neurol Sci"},{"issue":"4","key":"2044_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/cge.14180","volume":"102","author":"AR Lipman","year":"2022","unstructured":"Lipman AR, Fan X, Shen Y, Chung WK. Clinical and genetic characterization of CACNA1A-related disease. Clin Genet. 2022;102(4):288\u201395. https:\/\/doi.org\/10.1111\/cge.14180 . PubMed PMID: 35722745; PubMed Central PMCID: PMC9458680.","journal-title":"Clin Genet"},{"key":"2044_CR3","doi-asserted-by":"publisher","first-page":"2050313X1770604","DOI":"10.1177\/2050313X17706044","volume":"5","author":"DA Isaacs","year":"2017","unstructured":"Isaacs DA, Bradshaw MJ, Brown K, Hedera P. Case report of novel CACNA1A gene mutation causing episodic ataxia type 2. SAGE Open Med Case Rep. 2017;5:2050313X17706044. https:\/\/doi.org\/10.1177\/2050313X17706044 . PubMed PMID: 28540055; PubMed Central PMCID: PMC5431607.","journal-title":"SAGE Open Med Case Rep"},{"issue":"3","key":"2044_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.14802\/jmd.16028","volume":"9","author":"KD Choi","year":"2016","unstructured":"Choi KD, Choi JH. Episodic ataxias: clinical and genetic features. J Mov Disord. 2016;9(3):129\u201335. https:\/\/doi.org\/10.14802\/jmd.16028.","journal-title":"J Mov Disord"},{"key":"2044_CR5","doi-asserted-by":"publisher","unstructured":"Baloh R. Episodic ataxias 1 and 2. In: Handbook of Clinical Neurology [Internet]. Elsevier; 2012 [cited 2026 May 25]. pp. 595\u2013602. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780444518927000425https:\/\/doi.org\/10.1016\/B978-0-444-51892-7.00042-5","DOI":"10.1016\/B978-0-444-51892-7.00042-5"},{"issue":"1","key":"2044_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/ene.13765","volume":"26","author":"E Indelicato","year":"2019","unstructured":"Indelicato E, Nachbauer W, Karner E, Eigentler A, Wagner M, Unterberger I, et al. The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature. Eur J Neurol. 2019;26(1):66. https:\/\/doi.org\/10.1111\/ene.13765.","journal-title":"Eur J Neurol"},{"key":"2044_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejpn.2020.10.004","volume":"30","author":"T Gur-Hartman","year":"2021","unstructured":"Gur-Hartman T, Berkowitz O, Yosovich K, Roubertie A, Zanni G, Macaya A, et al. Clinical phenotypes of infantile onset CACNA1A-related disorder. Eur J Paediatr Neurol. 2021;30:144\u201354. https:\/\/doi.org\/10.1016\/j.ejpn.2020.10.004.","journal-title":"Eur J Paediatr Neurol"},{"issue":"7466","key":"2044_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12439","volume":"501","author":"Epi4K Consortium, Epilepsy Phenome\/Genome Project","year":"2013","unstructured":"Epi4K Consortium, Epilepsy Phenome\/Genome Project. De novo mutations in epileptic encephalopathies. Nature. 2013;501(7466):217\u201321. https:\/\/doi.org\/10.1038\/nature12439.","journal-title":"Nature"},{"key":"2044_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/B978-0-444-51892-7.00029-2","volume":"103","author":"A Solodkin","year":"2012","unstructured":"Solodkin A, Gomez CM. Spinocerebellar ataxia type 6. Handb Clin Neurol. 2012;103:461\u201373. https:\/\/doi.org\/10.1016\/B978-0-444-51892-7.00029-2 . PubMed PMID: 21827907.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"2044_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12883-020-01704-5","volume":"20","author":"R Nardello","year":"2020","unstructured":"Nardello R, Plicato G, Mangano GD, Gennaro E, Mangano S, Brighina F, et al. Two distinct phenotypes, hemiplegic migraine and episodic Ataxia type 2, caused by a novel common CACNA1A variant. BMC Neurol. 2020;20(1):155. https:\/\/doi.org\/10.1186\/s12883-020-01704-5 . PubMed PMID: 32336275; PubMed Central PMCID: PMC7183684.","journal-title":"BMC Neurol"},{"issue":"23","key":"2044_CR11","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1212\/WNL.0000000000002743","volume":"86","author":"EL Guterman","year":"2016","unstructured":"Guterman EL, Yurgionas B, Nelson AB. Pearls & oy-sters: episodic ataxia type 2: case report and review of the literature. Neurology. 2016;86(23):e239-41. https:\/\/doi.org\/10.1212\/WNL.0000000000002743.","journal-title":"Neurology"},{"issue":"11","key":"2044_CR12","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1113\/jphysiol.2009.186437","volume":"588","author":"S Rajakulendran","year":"2010","unstructured":"Rajakulendran S, Graves TD, Labrum RW, Kotzadimitriou D, Eunson L, Davis MB, et al. Genetic and functional characterisation of the P\/Q calcium channel in episodic ataxia with epilepsy: variation of CACNA1A in episodic ataxia and epilepsy. J Physiol. 2010;588(11):1905\u201313. https:\/\/doi.org\/10.1113\/jphysiol.2009.186437.","journal-title":"J Physiol"},{"issue":"1","key":"2044_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1056\/NEJM200107053450103","volume":"345","author":"A Ducros","year":"2001","unstructured":"Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001;345(1):17\u201324. https:\/\/doi.org\/10.1056\/NEJM200107053450103.","journal-title":"N Engl J Med"},{"issue":"9284","key":"2044_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(01)05971-2","volume":"358","author":"A Jouvenceau","year":"2001","unstructured":"Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi SM, Kullmann DM, et al. Human epilepsy associated with dysfunction of the brain P\/Q-type calcium channel. Lancet. 2001;358(9284):801\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(01)05971-2.","journal-title":"Lancet"},{"key":"2044_CR15","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.747","volume":"13","author":"A Hassan","year":"2023","unstructured":"Hassan A. Episodic ataxias: primary and secondary etiologies, treatment, and classification approaches. Tremor Hyperkinet Mov. 2023;13:9. https:\/\/doi.org\/10.5334\/tohm.747.","journal-title":"Tremor Hyperkinet Mov"},{"key":"2044_CR16","doi-asserted-by":"publisher","unstructured":"Muth C, Teufel J, Sch\u00f6ls L, Synofzik M, Franke C, Timmann D, et al. Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial. Neurol Clin Pract. 2021;11(4). https:\/\/doi.org\/10.1212\/CPJ.0000000000001017.","DOI":"10.1212\/CPJ.0000000000001017"},{"key":"2044_CR17","doi-asserted-by":"publisher","first-page":"29489","DOI":"10.1038\/srep29489","volume":"6","author":"S Jayabal","year":"2016","unstructured":"Jayabal S, Chang HHV, Cullen KE, Watt AJ. 4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6. Sci Rep. 2016;6:29489. https:\/\/doi.org\/10.1038\/srep29489 . PubMed PMID: 27381005; PubMed Central PMCID: PMC4933933.","journal-title":"Sci Rep"},{"issue":"20","key":"2044_CR18","doi-asserted-by":"publisher","first-page":"13284","DOI":"10.1073\/pnas.192242399","volume":"99","author":"A Tottene","year":"2002","unstructured":"Tottene A, Fellin T, Pagnutti S, Luvisetto S, Striessnig J, Fletcher C, et al. Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV 2.1 channels and decrease maximal CaV 2.1 current density in neurons. Proc Natl Acad Sci U S A. 2002;99(20):13284\u20139. https:\/\/doi.org\/10.1073\/pnas.192242399.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2044_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5334\/tohm.747","volume":"13","author":"A Hassan","year":"2023","unstructured":"Hassan A. Episodic ataxias: primary and secondary etiologies, treatment, and classification approaches. Tremor Hyperkinet Mov. 2023;13(1):9. https:\/\/doi.org\/10.5334\/tohm.747.","journal-title":"Tremor Hyperkinet Mov"},{"key":"2044_CR20","doi-asserted-by":"publisher","unstructured":"Yuan X, Zheng Y, Gao F, Sun W, Wang Z, Zhao G. Case Report: A Novel CACNA1A Mutation Caused Flunarizine-Responsive Type 2 Episodic Ataxia and Hemiplegic Migraine With Abnormal MRI of Cerebral White Matter. Front Neurol. 2022;13. https:\/\/doi.org\/10.3389\/fneur.2022.899813 . PubMed Central PMCID: PMC9168224.","DOI":"10.3389\/fneur.2022.899813"},{"issue":"6","key":"2044_CR21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/jon.12656","volume":"29","author":"E Nagarajan","year":"2019","unstructured":"Nagarajan E, Bollu PC, Manjamalai S, Yelam A, Qureshi AI. White matter hyperintensities in patients with sporadic hemiplegic migraine. J Neuroimaging. 2019;29(6):730\u20136. https:\/\/doi.org\/10.1111\/jon.12656.","journal-title":"J Neuroimaging"},{"issue":"7","key":"2044_CR22","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/jnnp-2020-322850","volume":"91","author":"V Di Stefano","year":"2020","unstructured":"Di Stefano V, Rispoli MG, Pellegrino N, Graziosi A, Rotondo E, Napoli C, et al. Diagnostic and therapeutic aspects of hemiplegic migraine. J Neurol Neurosurg Psychiatry. 2020;91(7):764\u201371. https:\/\/doi.org\/10.1136\/jnnp-2020-322850 . PubMed PMID: 32430436; PubMed Central PMCID: PMC7361005.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"2044_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1080\/00207454.2020.1835896","volume":"132","author":"M Batum","year":"2022","unstructured":"Batum M, K\u0131sabay Ak A, \u00c7etin G, \u00c7elebi HBG, \u00c7am S, Mavio\u011flu H. Coincidental occurance of episodic ataxia and multiple sclerosis: a case report and review of the literature. Int J Neurosci. 2022;132(7):656\u201361. https:\/\/doi.org\/10.1080\/00207454.2020.1835896 . PubMed PMID: 33045894.","journal-title":"Int J Neurosci"},{"issue":"15","key":"2044_CR24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1177\/0333102412459572","volume":"32","author":"D Magis","year":"2012","unstructured":"Magis D, Boon E, Coppola G, Daron A, Schoenen J. A novel CACNA1A mutation results in episodic ataxia with migrainous features without headache. Cephalalgia. 2012;32(15):1147\u20139. https:\/\/doi.org\/10.1177\/0333102412459572.","journal-title":"Cephalalgia"},{"issue":"2","key":"2044_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/glia.23723","volume":"68","author":"KA Pitman","year":"2020","unstructured":"Pitman KA, Ricci R, Gasperini R, Beasley S, Pavez M, Charlesworth J, et al. The voltage-gated calcium channel CaV1.2 promotes adult oligodendrocyte progenitor cell survival in the mouse corpus callosum but not motor cortex. Glia. 2020;68(2):376\u201392. https:\/\/doi.org\/10.1002\/glia.23723.","journal-title":"Glia"},{"key":"2044_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuroscience.2015.11.035","volume":"313","author":"TY Kim","year":"2016","unstructured":"Kim TY, Yoshimoto T, Aoyama Y, Niimi K, Takahashi E. Analysis of the protective effects of a neuronal Cav2.1 calcium channel in brain injury. Neuroscience. 2016;313:110\u201321. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.11.035.","journal-title":"Neuroscience"},{"key":"2044_CR27","unstructured":"Jen J. Familial Hemiplegic Migraine. In: GeneReviews [Internet]. Seattle: University of Washington; 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/"},{"issue":"6","key":"2044_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.12809\/hkmj198306","volume":"26","author":"HJ Wu","year":"2020","unstructured":"Wu HJ, Lau WL, Chan TYC, Chen SPL, Ko CH. Differentiating episodic ataxia type 2 from migraine: a case report. Hong Kong Med J. 2020;26(6):526\u20137. https:\/\/doi.org\/10.12809\/hkmj198306 . PubMed PMID: 33350965.","journal-title":"Hong Kong Med J"},{"key":"2044_CR29","doi-asserted-by":"publisher","first-page":"212576","DOI":"10.7573\/dic.212576","volume":"8","author":"D Orsucci","year":"2019","unstructured":"Orsucci D, Raglione LM, Mazzoni M, Vista M. Therapy of episodic ataxias: case report and review of the literature. Drugs Context. 2019;8:212576. https:\/\/doi.org\/10.7573\/dic.212576 . PubMed PMID: 30891074; PubMed Central PMCID: PMC6415777.","journal-title":"Drugs Context"},{"key":"2044_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2021.100334","volume":"23","author":"L Verriello","year":"2021","unstructured":"Verriello L, Carrera P, Pauletto G, Bernardini A, Valente M, Gigli GL. Case report and ten-year follow-up of episodic ataxia type 2 due to a novel variant in CACNA1A. eNeurologicalSci. 2021;23:100334. https:\/\/doi.org\/10.1016\/j.ensci.2021.100334.","journal-title":"eNeurologicalSci"},{"issue":"4","key":"2044_CR31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s12311-018-0931-8","volume":"17","author":"A Balck","year":"2018","unstructured":"Balck A, Tunc S, Schmitz J, Hollstein R, Kaiser FJ, Br\u00fcggemann N. A novel frameshift <italic>CACNA1A<\/italic> mutation causing episodic ataxia type 2. Cerebellum. 2018;17(4):504\u20136. https:\/\/doi.org\/10.1007\/s12311-018-0931-8.","journal-title":"Cerebellum"},{"issue":"2","key":"2044_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/00207454.2018.1486829","volume":"129","author":"X Ling","year":"2019","unstructured":"Ling X, Zhao DH, Zhao J, Shen B, Yang X. Episodic ataxia type 2 characterised by recurrent dizziness\/vertigo: a report of four cases. Int J Neurosci. 2019;129(2):103\u20139. https:\/\/doi.org\/10.1080\/00207454.2018.1486829 . PubMed PMID: 29883219.","journal-title":"Int J Neurosci"},{"issue":"8","key":"2044_CR33","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1007\/s10072-022-06144-2","volume":"43","author":"C Gonz\u00e1lez-Mingot","year":"2022","unstructured":"Gonz\u00e1lez-Mingot C, L\u00f3pez-Ortega R, Brieva-Ruiz L. The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2. Neurol Sci. 2022;43(8):5099\u2013101. https:\/\/doi.org\/10.1007\/s10072-022-06144-2.","journal-title":"Neurol Sci"},{"key":"2044_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5802650","volume":"2018","author":"S Lance","year":"2018","unstructured":"Lance S, Mossman S, Poke G. A novel <italic>CACNA1A<\/italic> nonsense variant [c.4054c>t (p.arg1352\u204e)] causing episodic ataxia type 2. Case Rep Neurol Med. 2018;2018:5802650. https:\/\/doi.org\/10.1155\/2018\/5802650.","journal-title":"Case Rep Neurol Med"},{"key":"2044_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105311","volume":"108","author":"G Argenziano","year":"2023","unstructured":"Argenziano G, Cavallieri F, Monfrini E, Gessani A, Russo M, Rizzi R, et al. Deconstructing speech alterations in episodic ataxia type 2: perceptual-acoustic analysis in a case due to <italic>CACNA1A<\/italic> gene mutation. Parkinsonism Relat Disord. 2023;108:105311. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105311.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2044_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12883-019-1491-3","volume":"19","author":"AS Ahuja","year":"2019","unstructured":"Ahuja AS, Rozen TD, Atwal PS. A sleep modulated Channelopathy: a novel CACNA1A pathogenic variant identified in episodic Ataxia type 2 and a potential link to sleep alleviated migraine. BMC Neurol. 2019;19(1):246. https:\/\/doi.org\/10.1186\/s12883-019-1491-3 . PubMed PMID: 31640633; PubMed Central PMCID: PMC6806495.","journal-title":"BMC Neurol"},{"issue":"9","key":"2044_CR37","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s10072-021-05368-y","volume":"42","author":"S Na","year":"2021","unstructured":"Na S, Kim T. Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by <italic>CACNA1A<\/italic> mutation: three case reports. Neurol Sci. 2021;42(9):3897\u20139. https:\/\/doi.org\/10.1007\/s10072-021-05368-y.","journal-title":"Neurol Sci"},{"issue":"1","key":"2044_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s13760-018-0895-y","volume":"118","author":"D Park","year":"2018","unstructured":"Park D, Kim SH, Lee YJ, Song GJ, Park JS. A novel CACNA1A mutation associated with episodic ataxia 2 presenting with periodic paralysis. Acta Neurol Belg. 2018;118(1):137\u20139. https:\/\/doi.org\/10.1007\/s13760-018-0895-y . PubMed PMID: 29442233.","journal-title":"Acta Neurol Belg"},{"issue":"10","key":"2044_CR39","doi-asserted-by":"publisher","first-page":"7039","DOI":"10.1007\/s00415-024-12636-2","volume":"271","author":"S Kim","year":"2024","unstructured":"Kim S, Choi JY, Kim JS, Kim HJ. Torsional saccadic palsy in episodic ataxia type 2. J Neurol. 2024;271(10):7039\u201341. https:\/\/doi.org\/10.1007\/s00415-024-12636-2.","journal-title":"J Neurol"},{"issue":"2","key":"2044_CR40","doi-asserted-by":"publisher","first-page":"e56362","DOI":"10.1371\/journal.pone.0056362","volume":"8","author":"Y Hu","year":"2013","unstructured":"Hu Y, Jiang H, Wang Q, Xie Z, Pan S. Identification of a novel nonsense mutation p.Tyr1957Ter of CACNA1A in a Chinese family with episodic ataxia 2. PLoS ONE. 2013;8(2):e56362. https:\/\/doi.org\/10.1371\/journal.pone.0056362 . PubMed PMID: 23441182; PubMed Central PMCID: PMC3575407.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"2044_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0022-510x(03)00008-x","volume":"210","author":"Z Matsuyama","year":"2003","unstructured":"Matsuyama Z, Murase M, Shimizu H, Aoki Y, Hayashi M, Hozumi I, et al. A novel insertion mutation of acetazolamide-responsive episodic ataxia in a Japanese family. J Neurol Sci. 2003;210(1\u20132):91\u20133. https:\/\/doi.org\/10.1016\/s0022-510x(03)00008-x.","journal-title":"J Neurol Sci"},{"issue":"5","key":"2044_CR42","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.parkreldis.2011.09.018","volume":"18","author":"M Nagappa","year":"2012","unstructured":"Nagappa M, Mundlamuri RC, Satishchandra P, Pal PK. Sleep benefit in a case of episodic ataxia. Parkinsonism Relat Disord. 2012;18(5):662\u20133. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.09.018.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2044_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1017\/s0317167100004728","volume":"33","author":"KA Scoggan","year":"2006","unstructured":"Scoggan KA, Friedman JH, Bulman DE. CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid. Can J Neurol Sci. 2006;33(1):68\u201372. https:\/\/doi.org\/10.1017\/s0317167100004728.","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"2044_CR44","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/(sici)1096-8628","volume":"77","author":"Q Yue","year":"1998","unstructured":"Yue Q, Jen JC, Thwe MM, Nelson SF, Baloh RW. De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia. Am J Med Genet. 1998;77(4):298\u2013301. https:\/\/doi.org\/10.1002\/(sici)1096-8628. )77:4\\textless298::aid-ajmg9\\textgreater3.0.co;2-j PubMed PMID: 9600739.","journal-title":"Am J Med Genet"},{"issue":"2","key":"2044_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1001\/archneur.62","volume":"62","author":"SD Spacey","year":"2005","unstructured":"Spacey SD, Materek LA, Szczygielski BI, Bird TD. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol. 2005;62(2):314\u20136. https:\/\/doi.org\/10.1001\/archneur.62. .2.314 PubMed PMID: 15710862.","journal-title":"Arch Neurol"},{"issue":"11","key":"2044_CR46","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1136\/jnnp.2008.159103","volume":"80","author":"P Bertholon","year":"2009","unstructured":"Bertholon P, Chabrier S, Riant F, Tournier-Lasserve E, Peyron R. Episodic ataxia type 2: unusual aspects in clinical and genetic presentation. Special emphasis in childhood. J Neurol Neurosurg Psychiatry. 2009;80(11):1289\u201392. https:\/\/doi.org\/10.1136\/jnnp.2008.159103.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"2044_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jns.2009.01.005","volume":"280","author":"E Cuenca-Le\u00f3n","year":"2009","unstructured":"Cuenca-Le\u00f3n E, Banchs I, Serra SA, Latorre P, Fern\u00e0ndez-Castillo N, Corominas R, et al. Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene. J Neurol Sci. 2009;280(1\u20132):10\u20134. https:\/\/doi.org\/10.1016\/j.jns.2009.01.005.","journal-title":"J Neurol Sci"},{"issue":"4","key":"2044_CR48","first-page":"58","volume":"7","author":"R Shervin Badv","year":"2013","unstructured":"Shervin Badv R, Niksirat A. Downward vertical gaze palsy as a prominent manifestation of episodic ataxia type 2: a case report. Iran J Child Neurol. 2013;7(4):58\u201360. PubMed PMID: 24665320; PubMed Central PMCID: PMC3943042.","journal-title":"Iran J Child Neurol"},{"key":"2044_CR49","doi-asserted-by":"publisher","unstructured":"Park S, Bae H, Kwon S, Lee YJ. Episodic Ataxia Type 2 Presenting with Fluctuating Weakness in a Child with a De Novo CACNA1A Variant. Child Basel Switz. 2026;13(4). https:\/\/doi.org\/10.3390\/children13040488 . PubMed PMID: 42073066.","DOI":"10.3390\/children13040488"},{"issue":"5","key":"2044_CR50","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/jnnp.74.5.688","volume":"74","author":"S Mechtcheriakov","year":"2003","unstructured":"Mechtcheriakov S. Schizophrenia and episodic ataxia type 2. J Neurol Neurosurg Psychiatry. 2003;74(5):688\u20139. https:\/\/doi.org\/10.1136\/jnnp.74.5.688 . PubMed Central PMCID: PMC1738421.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"2044_CR51","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1212\/01.wnl.0000125691.74109.53","volume":"62","author":"M Strupp","year":"2004","unstructured":"Strupp M, Kalla R, Dichgans M, Freilinger T, Glasauer S, Brandt T. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology. 2004;62(9):1623\u20135. https:\/\/doi.org\/10.1212\/01.wnl.0000125691.74109.53 . PubMed PMID: 15136697.","journal-title":"Neurology"},{"issue":"7","key":"2044_CR52","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1526-4610.2009.01464.x","volume":"49","author":"MS Robbins","year":"2009","unstructured":"Robbins MS, Lipton RB, Laureta EC, Grosberg BM. CACNA1A nonsense mutation is associated with basilar-type migraine and episodic ataxia type 2. Headache. 2009;49(7):1042\u20136. https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01464.x.","journal-title":"Headache"},{"issue":"2","key":"2044_CR53","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00415-004-0299-1","volume":"251","author":"H Harno","year":"2004","unstructured":"Harno H, Hirvonen T, Kaunisto MA, Aalto H, Levo H, Isotalo E, et al. Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2). J Neurol. 2004;251(2):232\u20134. https:\/\/doi.org\/10.1007\/s00415-004-0299-1.","journal-title":"J Neurol"},{"issue":"10","key":"2044_CR54","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.braindev.2019.06.006","volume":"41","author":"A Hirasawa-Inoue","year":"2019","unstructured":"Hirasawa-Inoue A, Ishiyama A, Takeshita E, Shimizu-Motohashi Y, Saito T, Komaki H, et al. Single-fiber electromyography-based diagnosis of CACNA1A mutation in children: a potential role of the electrodiagnosis in the era of whole exome sequencing. Brain Dev. 2019;41(10):905\u20139. https:\/\/doi.org\/10.1016\/j.braindev.2019.06.006.","journal-title":"Brain Dev"},{"issue":"1","key":"2044_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5507\/bp.2016.066","volume":"161","author":"A Petrovicova","year":"2017","unstructured":"Petrovicova A, Brozman M, Kurca E, Gobo T, Dluha J, Kalmarova K, et al. Novel missense variant of CACNA1A gene in a Slovak family with episodic ataxia type 2. Biomed Pap. 2017;161(1):107\u201310. https:\/\/doi.org\/10.5507\/bp.2016.066.","journal-title":"Biomed Pap"},{"issue":"6","key":"2044_CR56","doi-asserted-by":"publisher","first-page":"103530","DOI":"10.1016\/j.ejmg.2018.08.011","volume":"62","author":"C Angelini","year":"2019","unstructured":"Angelini C, Van Gils J, Bigourdan A, Jouk PS, Lacombe D, Menegon P, et al. Major intra-familial phenotypic heterogeneity and incomplete penetrance due to a CACNA1A pathogenic variant. Eur J Med Genet. 2019;62(6):103530. https:\/\/doi.org\/10.1016\/j.ejmg.2018.08.011.","journal-title":"Eur J Med Genet"},{"issue":"5","key":"2044_CR57","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00415-014-7310-2","volume":"261","author":"W Nachbauer","year":"2014","unstructured":"Nachbauer W, Nocker M, Karner E, Stankovic I, Unterberger I, Eigentler A, et al. Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature. J Neurol. 2014;261(5):983\u201391. https:\/\/doi.org\/10.1007\/s00415-014-7310-2.","journal-title":"J Neurol"},{"issue":"3","key":"2044_CR58","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00415-025-12941-4","volume":"272","author":"L Verriello","year":"2025","unstructured":"Verriello L, Pez S, Pauletto G, Valente M. Efficacy and safety of 4-aminopyridine in episodic ataxia type 2: a case series. J Neurol. 2025;272(3):205. https:\/\/doi.org\/10.1007\/s00415-025-12941-4 . PubMed PMID: 39954114.","journal-title":"J Neurol"},{"key":"2044_CR59","doi-asserted-by":"publisher","unstructured":"Shimazaki H. Effects of Levetiracetam on Episodic Ataxia Type 2 and Spinocerebellar Ataxia Type 6 with Episodic Ataxic Symptoms: A Case Series. Genes. 2025;16(3). https:\/\/doi.org\/10.3390\/genes16030335 . PubMed PMID: 40149486.","DOI":"10.3390\/genes16030335"},{"issue":"1","key":"2044_CR60","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5582\/irdr.2018.01133","volume":"8","author":"H Algahtani","year":"2019","unstructured":"Algahtani H, Shirah B, Algahtani R, Al-Qahtani MH, Abdulkareem AA, Naseer MI. A novel mutation in CACNA1A gene in a Saudi female with episodic ataxia type 2 with no response to acetazolamide or 4-aminopyridine. Intract Rare Dis Res. 2019;8(1):67\u201371. https:\/\/doi.org\/10.5582\/irdr.2018.01133.","journal-title":"Intract Rare Dis Res"},{"key":"2044_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113810","author":"C Stendel","year":"2020","unstructured":"Stendel C, D\u2019Adamo MC, Wiessner M, Dusl M, Cenciarini M, Belia S, et al. Association of a novel splice site mutation in P\/Q-type calcium channels with childhood epilepsy and late-onset slowly progressive non-episodic cerebellar ataxia. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21113810.","journal-title":"Int J Mol Sci"},{"key":"2044_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jns.2017.07.040","volume":"381","author":"M Shimmura","year":"2017","unstructured":"Shimmura M, Uehara T, Yamashita K, Shigeto H, Yamasaki R, Ishikawa K, et al. Slowed abduction during smooth pursuit eye movement in episodic ataxia type 2 with a novel CACNA1A mutation. J Neurol Sci. 2017;381:4\u20136. https:\/\/doi.org\/10.1016\/j.jns.2017.07.040.","journal-title":"J Neurol Sci"},{"issue":"8","key":"2044_CR63","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp.2008.163402","volume":"81","author":"R Romaniello","year":"2010","unstructured":"Romaniello R, Zucca C, Tonelli A, Bonato S, Baschirotto C, Zanotta N, et al. A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation. J Neurol Neurosurg Psychiatry. 2010;81(8):840\u20133. https:\/\/doi.org\/10.1136\/jnnp.2008.163402.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"2044_CR64","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000315145","volume":"64","author":"J Jung","year":"2010","unstructured":"Jung J, Testard H, Tournier-Lasserve E, Riant F, Vallet AE, Berroir S, et al. Phenotypic variability of episodic ataxia type 2 mutations: a family study. Eur Neurol. 2010;64(2):114\u20136. https:\/\/doi.org\/10.1159\/000315145.","journal-title":"Eur Neurol"},{"issue":"2","key":"2044_CR65","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejpn.2008.02.011","volume":"13","author":"DI Zafeiriou","year":"2009","unstructured":"Zafeiriou DI, Lehmann-Horn F, Vargiami E, Teflioudi E, Ververi A, Jurkat-Rott K. Episodic ataxia type 2 showing ictal hyperhidrosis with hypothermia and interictal chronic diarrhea due to a novel CACNA1A mutation. Eur J Paediatr Neurol. 2009;13(2):191\u20133. https:\/\/doi.org\/10.1016\/j.ejpn.2008.02.011.","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"2044_CR66","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1212\/01.wnl.0000176069.64200.28","volume":"65","author":"P Imbrici","year":"2005","unstructured":"Imbrici P, Eunson LH, Graves TD, Bhatia KP, Wadia NH, Kullmann DM, et al. Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology. 2005;65(6):944\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000176069.64200.28.","journal-title":"Neurology"},{"issue":"9","key":"2044_CR67","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/mds.22071","volume":"23","author":"M L\u00f6hle","year":"2008","unstructured":"L\u00f6hle M, Schrempf W, Wolz M, Reichmann H, Storch A. Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2\u2013a video case report. Mov Disord. 2008;23(9):1314\u20136. https:\/\/doi.org\/10.1002\/mds.22071 . PubMed PMID: 18442126.","journal-title":"Mov Disord"},{"issue":"3","key":"2044_CR68","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1086\/318804","volume":"68","author":"S Guida","year":"2001","unstructured":"Guida S, Trettel F, Pagnutti S, Mantuano E, Tottene A, Veneziano L, et al. Complete loss of P\/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet. 2001;68(3):759\u201364. https:\/\/doi.org\/10.1086\/318804.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2044_CR69","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1468-2982.2009.01958","volume":"30","author":"C Cleves","year":"2010","unstructured":"Cleves C, Parikh S, Rothner AD, Tepper SJ. Link between confusional migraine, hemiplegic migraine and episodic ataxia type 2: hypothesis, family genealogy, gene typing and classification. Cephalalgia. 2010;30(6):740\u20133. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01958. .x PubMed PMID: 19624685.","journal-title":"Cephalalgia"},{"issue":"4","key":"2044_CR70","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-004-0899-y","volume":"108","author":"Y Mochizuki","year":"2004","unstructured":"Mochizuki Y, Kawata A, Mizutani T, Takamoto K, Hayashi H, Taki K, et al. Hereditary paroxysmal ataxia with mental retardation: a clinicopathological study in relation to episodic ataxia type 2. Acta Neuropathol. 2004;108(4):345\u20139. https:\/\/doi.org\/10.1007\/s00401-004-0899-y.","journal-title":"Acta Neuropathol"},{"issue":"1\u20132","key":"2044_CR71","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jns.2010.06.024","volume":"296","author":"N Melzer","year":"2010","unstructured":"Melzer N, Classen J, Reiners K, Buttmann M. Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel CaV2.1 single amino acid substitution R2090Q. J Neurol Sci. 2010;296(1\u20132):104\u20136. .024 PubMed PMID: 20663518.","journal-title":"J Neurol Sci"},{"issue":"12","key":"2044_CR72","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/mds.25198","volume":"27","author":"S Fujioka","year":"2012","unstructured":"Fujioka S, Rayaprolu S, Sundal C, Broderick DF, Langley WA, Shoffner J, et al. A novel de novo pathogenic mutation in the CACNA1A gene. Mov Disord. 2012;27(12):1578\u20139. https:\/\/doi.org\/10.1002\/mds.25198.","journal-title":"Mov Disord"},{"issue":"12","key":"2044_CR73","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1007\/s00415-013-7099-4","volume":"260","author":"S Kipfer","year":"2013","unstructured":"Kipfer S, Jung S, Lemke JR, Kipfer-Kauer A, Howell JP, Kaelin-Lang A, et al. Novel CACNA1A mutation(s) associated with slow saccade velocities. J Neurol. 2013;260(12):3010\u20134. https:\/\/doi.org\/10.1007\/s00415-013-7099-4.","journal-title":"J Neurol"},{"issue":"1\u20132","key":"2044_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2007.01.008","volume":"254","author":"F Cricchi","year":"2007","unstructured":"Cricchi F, Di Lorenzo C, Grieco GS, Rengo C, Cardinale A, Racaniello M, et al. Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop. J Neurol Sci. 2007;254(1\u20132):69\u201371. https:\/\/doi.org\/10.1016\/j.jns.2007.01.008.","journal-title":"J Neurol Sci"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02044-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:10:16Z","timestamp":1786165816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-026-02044-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":74,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2044"],"URL":"https:\/\/doi.org\/10.1007\/s12311-026-02044-9","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants performed by any of the authors beyond standard clinical care.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient","order":2,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":3,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"103"}}